AR
A RENUKA DEVI Dirigeant
Other
IN IN · SEBI (PIT + SAST)
Discover the detailed record of transactions filed by A RENUKA DEVI, Dirigeant. Insider active across 1 companies, notably Gland Pharma Limited. In total, 22 disclosures have been logged. The latest transaction was disclosed on 20 June 2022 — Sale. Regulator: SEBI (PIT + SAST). All data is accessible without signup.
Declarations 22 total
€15,440 493 shares @ €31.3191
Equity Shares
SEBI:4052c9dc58f8f214552484caf6c85df3bbe46318 · 20 Jun 2022
€16,519 500 shares @ €33.0388
Equity Shares
SEBI:61a6fee8883be6d49411f799fc608413ba06701d · 15 Jun 2022
€67,129 2,000 shares @ €33.5645
Equity Shares
SEBI:9902c52c5e754e6a770fcc73ea80f3cf5a8b0c87 · 14 Jun 2022
€50,539 1,500 shares @ €33.6928
Equity Shares
SEBI:4926003f304e21aaec225415f91d86b12bd6dd09 · 10 Jun 2022
€16,923 500 shares @ €33.8466
Equity Shares
SEBI:c8deb44f8f331ec0a87d6715b8715bc97a1323b8 · 6 Jun 2022
€17,419 500 shares @ €34.8376
Equity Shares
SEBI:fd38be5906584cbc40c566d83a488441fcbe008e · 27 May 2022
€33,459 1,000 shares @ €33.459
Equity Shares
SEBI:b2de7ba50a1a0f3c4facef4d01ff79b7285a85b7 · 26 May 2022
€30,261 4,500 shares @ €6.7246
Equity Shares
SEBI:3b87b2b152557a601cb676514908ade1371176f1 · 29 Apr 2022
Ideal exit: 24 Jan 2023 (T+270) €27,160 700 shares @ €38.7999
Equity Shares
SEBI:6dbad3b7fb05036d1ba5fc258f5bcb32bd9db836 · 30 Mar 2022
€46,501 1,200 shares @ €38.7511
Equity Shares
SEBI:c95234a02cb23a1da48b78f875d1a194c425b637 · 28 Mar 2022
€7,877 200 shares @ €39.3847
Equity Shares
SEBI:aa1d957b9ce8e75539b75e20132171b8c7dcbe1e · 16 Mar 2022
€4,656 100 shares @ €46.5627
Equity Shares
SEBI:a1eac1225a92743be6c6305b3a7fdc6a8932b68a · 30 Dec 2021
€21,544 500 shares @ €43.0881
Equity Shares
SEBI:e8ad462942aedc0ed899460335ace4a7cb152e36 · 20 Dec 2021
€21,031 500 shares @ €42.0623
Equity Shares
SEBI:241a96509258b7151a8e27a82ce869df096f777a · 17 Dec 2021
€21,182 500 shares @ €42.364
Equity Shares
SEBI:f862253526aaa851d8b38c6f8fc9c05854710e1a · 14 Dec 2021
€42,713 1,000 shares @ €42.7126
Equity Shares
SEBI:39c6caa1e23289d12a52f30172231a2bdb719158 · 2 Dec 2021
€94,799 2,250 shares @ €42.1328
Equity Shares
SEBI:e12e95b04dec4d7496b50e1d924c6e457d1b5545 · 29 Nov 2021
€37,661 1,000 shares @ €37.661 0.0000% mcap 28.7% of flow
Equity Shares
SEBI:b9709379ce01cd7bcf98b9130e105c8baf1e8c5d · 28 May 2021
Ideal exit: 22 Feb 2022 (T+270) €36,538 1,000 shares @ €36.5381 0.0000% mcap 27.8% of flow
Equity Shares
SEBI:d3cd3c4197eeabd113eccf746fd95faf8dcb6dd4 · 28 May 2021
€29,816 797 shares @ €37.4098 0.0000% mcap 22.7% of flow
Equity Shares
SEBI:85234e973f5644fc786017ba9c4569bf4b307b50 · 26 May 2021
€27,058 750 shares @ €36.0769 0.0000% mcap 20.6% of flow
Equity Shares
SEBI:e6458d918aa00cc975e4894f321a55ba134feadf · 25 May 2021
€359 10 shares @ €35.8528 0.0000% mcap 0.3% of flow
Equity Shares
SEBI:9259619745d8ab9fb81b221463d285a56f2b1e5e · 25 May 2021
About A RENUKA DEVI A Renuka Devi holds an executive role at Gland Pharma Limited. Gland Pharma is an Indian pharmaceutical company specializing in the manufacture of injectable medications. As an executive, she is responsible for the strategic and operational management of the company, aiming to improve product quality and strengthen the company's market position.